Literature DB >> 11852699

Comparative evaluation of co-processed lactose and microcrystalline cellulose with their physical mixtures in the formulation of folic acid tablets.

Armand Michoel1, Patrick Rombaut, Ann Verhoye.   

Abstract

In this study, a new co-processed filler-binder ingredient for direct compression, MicroceLac 100, was compared with three different lactoses mixed with microcrystalline cellulose. The aim was to improve a folic acid tablet formulation. Therefore, the influence of drug addition to these mixtures was studied with regard to flow and binding properties. Another part of the study was focused on the interaction and segregation behavior of the drug. MicroceLac 100 showed superior flow and binding properties. Good adhesion of folic acid to the MicroceLac 100 particles could decrease demixing and segregation. The improved characteristics of co-processed material are attributed to spray drying. Sodium stearyl fumarate was chosen as a lubricant, based on ejection force measurements. The content uniformity of the newly formulated direct compression tablets met the official requirements.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852699     DOI: 10.1081/pdt-120002233

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  Spherical composite particles of rice starch and microcrystalline cellulose: a new coprocessed excipient for direct compression.

Authors:  Vasinee Limwong; Narueporn Sutanthavibul; Poj Kulvanich
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

Review 2.  Chitin and chitosan as direct compression excipients in pharmaceutical applications.

Authors:  Adnan A Badwan; Iyad Rashid; Mahmoud M H Al Omari; Fouad H Darras
Journal:  Mar Drugs       Date:  2015-03-19       Impact factor: 5.118

3.  Understanding the Performance of a Novel Direct Compression Excipient Comprising Roller Compacted Chitin.

Authors:  Deeb Abu Fara; Linda Al-Hmoud; Iyad Rashid; Babur Z Chowdhry; Adnan Badwan
Journal:  Mar Drugs       Date:  2020-02-17       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.